GL
Gemina Laboratories Ltd.
GLABF · OTC
$0.05 +0.00% (+$0.00)
Market Cap $5.28M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.08
60.0% upside
Trenutna cena
$0.05
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica GLABF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/S 245.74x
EV/FFO N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 10,354.70%
Op. margin 9,865.92%
FCF margin 2,377.07%
Quality
57 /100
Average ROA 137.11%
Asset turnover 0.01x
ROIC 45.26%
Debt
0 /100
High Int. coverage -27.05x
Current ratio 0.07x
Net debt/EBITDA N/A
Stability
62 /100
Moderate EPS volatility 10.93%
Profitable years 0
Beta -0.07x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o GLABF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Crandall Greene
Employees
6
Headquarters
Burnaby